MarketPulse
financial resultsconference callDeep TMS

BrainsWay Sets March 11 Date for 2025 Full-Year Results and Earnings Call

GlobeNewswire Inc.GlobeNewswire Inc.
|||1 min read
Key Takeaway

BrainsWay will release 2025 full-year financial results on March 11, 2026, followed by an 8:30 AM ET earnings call to discuss performance and operational updates.

BrainsWay Sets March 11 Date for 2025 Full-Year Results and Earnings Call
$BWAYneutral

BrainsWay Ltd., a developer of noninvasive neurostimulation technologies, announced that it will release its fourth quarter and full year 2025 financial results on March 11, 2026. The company has scheduled a conference call for 8:30 AM Eastern Time to discuss the reported results and provide updates on operational performance.

The earnings call will offer investors and analysts an opportunity to review the company's financial performance across the full calendar year 2025, including fourth quarter metrics. BrainsWay will address key financial indicators and operational developments during the presentation and subsequent question-and-answer session.

Topics

financial resultsconference callDeep TMSneurostimulationFDA-cleared indicationsmajor depressive disorderobsessive-compulsive disordersmoking addiction

Source: GlobeNewswire Inc.

Back to newsPublished Feb 25

Related Coverage

GlobeNewswire Inc.

Sika AG Shareholders Approve Board, Boost Dividend to CHF 3.70 Per Share

Sika AG shareholders approved CHF 3.70 dividend and board re-election at 2026 AGM, with company reporting CHF 11.20B sales and 33,700 employees globally.

SXYAY
GlobeNewswire Inc.

17EdTech Posts Narrower Loss Despite Revenue Decline as AI Product Gains Traction

17EdTech reports Q4 revenue growth of 6.4% YoY and significant margin expansion, though full-year revenues declined 44% due to business model shift. New AI product 'Yiqi Aixue' shows strong pre-sale demand.

YQ
The Motley Fool

Slide Insurance Posts $444M Profit on Strong Revenue Growth; Insider Trims Position

Slide Insurance reported $444M net income and $1.16B revenue, up 36% YoY. Director sold $1M in shares via pre-arranged plan while maintaining substantial stake.

SLDE
Benzinga

Alfa Laval Sets Q1 2026 Earnings Release; Conference Call Scheduled for April 22

Alfa Laval will release Q1 2026 earnings April 22, 2026, followed by investor conference call hosted by CEO Tom Erixon and CFO Fredrik Ekström.

ALFVY
GlobeNewswire Inc.

IMUNON Sets March 31 Call to Detail 2025 Results, OVATION 3 Trial Progress

$IMNN to discuss 2025 results and OVATION 3 Phase 3 trial progress for IMNN-001 ovarian cancer immunotherapy on March 31, 2026.

IMNN
GlobeNewswire Inc.

GEN Restaurant Group to Report 2025 Results as Korean BBQ Chain Expands

$GENK to discuss Q4 and full-year 2025 earnings on March 31, 2026, with 59+ company-owned locations driving growth.

GENK